Equity Research, Broker Reports, and media content on PHARMA MAR SA

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about PHARMA MAR SA
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on PHARMA MAR SA. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
01Dec16 08:00 PRN PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 in CD13-Expressing Tumor-Cells
28Nov16 02:05 PRN PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors
28Nov16 12:05 PRN PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors
16Nov16 01:45 PRN PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.
10Nov16 08:45 PRN PharmaMar Shows New Clinical Data With Yondelis® in Different Sarcoma Subtypes at CTOS 2016
31Oct16 01:00 PRN PharmaMar is Present at the 16th International Gynecologic Cancer Society Meeting With New Evidence on Yondelis®
31Oct16 09:00 PRN PharmaMar is Present at the 16th International Gynecologic Cancer Society Meeting With New Evidence on Yondelis®
  • Frequency of research reports

     

  • Research reports on

    PHARMA MAR SA

  • Providers covering

    PHARMA MAR SA